Related Experiment Video
Updated: Jun 4, 2026

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
Inhibition of NF-κB activation sensitizes U937 cells to 3'-azido-3'-deoxythymidine induced apoptosis
C Matteucci1, A Minutolo, E Balestrieri
1Department of Experimental Medicine and Biochemical Sciences, University of Rome 'Tor Vergata', Italy.
Abstract:
In this study, we investigated molecular mechanisms underlying low susceptibility to apoptosis induced by the nucleoside analog azidothymidine (AZT) and the role of nuclear factor-κB (NF-κB) activation in these phenomena. A preliminary screening in different cell lines indicated U937 monocytic cell line as suitable to this purpose. Treatment of U937 cells even with suprapharmacological concentrations of AZT induced only moderate levels of apoptosis. Surprisingly, SuperArray analysis showed that AZT induced the transcriptional activity of both pro- and anti-apoptotic genes. Interestingly, moreover, several genes upregulated by AZT were NF-κB related. In fact, AZT, after an initial inhibition of NF-κB activation with respect to control, induced a transient, but consistent, increase in NF-κB-binding activity. Inhibition of NF-κB activation in U937 cells, stably transfected with a dominant-negative IκBα or by pharmacological treatment, sensitized them to apoptosis induced by AZT and impaired the upregulation of anti-apoptotic genes in response to AZT treatment, with respect to control cells. These results indicate that NF-κB activation by AZT has a role in protecting target cells from apoptotic cell death, improving our understanding of the toxicology and the therapeutic usage of this drug.
Insights
Azidothymidine (AZT) treatment activates nuclear factor-kappa B (NF-κB), a mechanism that protects cells from apoptosis. Inhibiting NF-κB increases AZT-induced cell death, revealing its role in drug toxicology.
Area of Science:
- Molecular Biology
- Cell Biology
- Pharmacology
Background:
- Azidothymidine (AZT) is a nucleoside analog used in antiviral therapy.
- Understanding the molecular mechanisms of AZT-induced apoptosis is crucial for its therapeutic application and toxicology.
- Nuclear Factor-kappa B (NF-κB) is a key transcription factor involved in cellular responses, including apoptosis.
Purpose of the Study:
- To investigate the molecular mechanisms behind the low susceptibility to apoptosis induced by AZT.
- To elucidate the role of Nuclear Factor-kappa B (NF-κB) activation in AZT-induced apoptosis.
- To explore the implications for AZT's therapeutic use and toxicology.
Main Methods:
- Utilized U937 monocytic cell line for apoptosis studies.
- Performed SuperArray analysis to assess gene transcriptional activity.
- Investigated NF-κB activation using binding assays and dominant-negative IκBα transfection.
- Employed pharmacological treatments to inhibit NF-κB activation.
Main Results:
- AZT treatment induced moderate apoptosis in U937 cells, even at high concentrations.
- AZT modulated the transcriptional activity of both pro- and anti-apoptotic genes.
- AZT induced a transient but significant increase in NF-κB binding activity.
- Inhibition of NF-κB sensitized cells to AZT-induced apoptosis and impaired anti-apoptotic gene upregulation.
Conclusions:
- NF-κB activation by AZT plays a protective role against apoptosis.
- This finding enhances the understanding of AZT's toxicology.
- The study provides insights into the therapeutic usage of AZT.
More Related Videos
04:20Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity
Published on: February 9, 2024
09:18Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death
Published on: December 27, 2016
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
NF-kB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...